Michael S. Cuffe Hca Healthcare, Inc. (HCA) insider trading activity

Michael S. Cuffe is EVP and Chief Clinical Officer of HCA Healthcare, Inc.. Currently has a direct ownership of 29,678 shares of HCA, which is worth approximately $9.04 Million. The most recent transaction as insider was on Sep 12, 2024, when has been sold 8,358 shares (Common Stock) at a price of $385.42 per share, resulting in proceeds of $3,221,340. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.7K

0% 3M change

3.11% 12M change

Total Value Held $9.04 Million

Michael S. Cuffe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 12 2024	SELL Open market or private sale	$3,221,340 $385.42 p/Share	8,358 Reduced 21.97%	29,678 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$5,302,592 $386.43 p/Share	13,722 Reduced 26.51%	38,036 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	$3,206,899 $145.24 p/Share	22,080 Added 29.9%	51,758 Common Stock
May 09 2024	SELL Open market or private sale	$1,999,829 $316.88 p/Share	6,311 Reduced 17.56%	29,623 Common Stock
May 08 2024	SELL Bona fide gift	-	4,500 Reduced 11.13%	35,934 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$3,883,143 $314.45 p/Share	12,349 Reduced 23.4%	40,434 Common Stock
May 07 2024	BUY Exercise of conversion of derivative security	$2,594,859 $139.06 p/Share	18,660 Added 26.12%	52,783 Common Stock
May 06 2024	SELL Open market or private sale	$494,400 $309.0 p/Share	1,600 Reduced 4.48%	34,123 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$1,916,712 $308.55 p/Share	6,212 Reduced 14.82%	35,696 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	16,980 Added 28.83%	41,908 Common Stock
Jan 31 2024	SELL Open market or private sale	$981,728 $306.79 p/Share	3,200 Reduced 11.38%	24,928 Common Stock
Jan 31 2024	SELL Bona fide gift	-	728 Reduced 2.52%	28,128 Common Stock
Apr 28 2023	SELL Open market or private sale	$3,571,428 $284.44 p/Share	12,556 Reduced 30.37%	28,783 Common Stock
Apr 24 2023	SELL Payment of exercise price or tax liability	$5,571,570 $286.25 p/Share	19,464 Reduced 32.01%	41,339 Common Stock
Apr 24 2023	BUY Exercise of conversion of derivative security	$3,239,143 $101.16 p/Share	32,020 Added 34.5%	60,803 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,112,338 $262.84 p/Share	4,232 Reduced 12.83%	28,750 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	12,160 Added 26.94%	32,982 Common Stock
Feb 01 2023	SELL Open market or private sale	$1,028,440 $257.11 p/Share	4,000 Reduced 16.11%	20,822 Common Stock
Oct 31 2022	SELL Bona fide gift	-	450 Reduced 1.78%	24,822 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$892,918 $244.1 p/Share	3,658 Reduced 12.7%	25,143 Common Stock
Feb 18 2022	BUY Grant, award, or other acquisition	-	10,840 Added 27.35%	28,801 Common Stock
Aug 03 2021	SELL Open market or private sale	$629,775 $251.91 p/Share	2,500 Reduced 12.25%	17,914 Common Stock
Apr 29 2021	SELL Payment of exercise price or tax liability	$766,160 $201.94 p/Share	3,794 Reduced 8.86%	39,033 Common Stock
Apr 29 2021	SELL Open market or private sale	$3,761,356 $201.53 p/Share	18,664 Reduced 47.82%	20,369 Common Stock
Apr 29 2021	BUY Exercise of conversion of derivative security	$486,023 $81.96 p/Share	5,930 Added 12.16%	42,827 Common Stock

MSC

Michael S. Cuffe

EVP and Chief Clinical Officer

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCA shares.

Notify only if

Value

Insider Trading

Get notified when an Hca Healthcare, Inc. insider buys or sells HCA shares.

Notify only if

Operation

Value

Type

News

Receive news related to HCA Healthcare, Inc.

Track Activities on HCA

Account